Aliskiren Hemifumarate/Valsartan
- Generic Name
- Aliskiren Hemifumarate/Valsartan
Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes
Phase 4
Terminated
- Conditions
- HypertensionStage 2 HypertensionDiabetes
- Interventions
- Drug: Placebo of Valturna TabletDrug: Placebo Capsule
- First Posted Date
- 2011-06-08
- Last Posted Date
- 2013-03-21
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 975
- Registration Number
- NCT01368536
- Locations
- 🇵🇷
Novartis Investigative Site, San Juan, Puerto Rico
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath